MAX
Company Analysis MedinCell S.A.
1. Summary
Advantages
- The stock's return over the last year (392.98%) is higher than the sector average (20.76%).
- Current debt level 64.96% is below 100% and has decreased over 5 years from 121.06%.
- The company's current efficiency (ROE=112.65%) is higher than the sector average (ROE=14.4%)
Disadvantages
- Price (34.39 $) is higher than fair price (22.19 $)
- Dividends (0%) are below the sector average (1.69%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| MedinCell S.A. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 0.6% | -0.8% |
| 90 days | 393% | 4.9% | 3.6% |
| 1 year | 393% | 20.8% | 12.3% |
MDCLF vs Sector: MedinCell S.A. has outperformed the "Healthcare" sector by 372.22% over the past year.
MDCLF vs Market: MedinCell S.A. has outperformed the market by 380.63% over the past year.
Highly volatile price: MDCLF is significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical deviations of more than +/- 15% per week.
Long period: MDCLF with weekly volatility of 7.56% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (34.39 $) is higher than the fair price (22.19 $).
Price is higher than fair: The current price (34.39 $) is 35.5% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-54.28) is lower than that of the sector as a whole (41.11).
P/E vs Market: The company's P/E (-54.28) is lower than that of the market as a whole (47.24).
5.3. P/BV
P/BV vs Sector: The company's P/BV (-61.14) is lower than that of the sector as a whole (3.58).
P/BV vs Market: The company's P/BV (-61.14) is lower than that of the market as a whole (4.3).
5.5. P/S
P/S vs Sector: The company's P/S indicator (39.18) is higher than that of the sector as a whole (3.9).
P/S vs Market: The company's P/S indicator (39.18) is higher than that of the market as a whole (12.17).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-16.75) is lower than that of the sector as a whole (15.97).
EV/Ebitda vs Market: The company's EV/Ebitda (-16.75) is lower than that of the market as a whole (24.87).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -0.61% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-0.61%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-45.01%).
6.4. ROE
ROE vs Sector: The company's ROE (112.65%) is higher than that of the sector as a whole (14.4%).
ROE vs Market: The company's ROE (112.65%) is higher than that of the market as a whole (50.3%).
6.6. ROA
ROA vs Sector: The company's ROA (-20.38%) is lower than that of the sector as a whole (7.44%).
ROA vs Market: The company's ROA (-20.38%) is lower than that of the market as a whole (35.27%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.06%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.86%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.69%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Based on sources: porti.ru
